- Home
- STRO vs LWAY Comparison
STRO vs LWAY Comparison
Compare STRO & LWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- LWAY
- Stock Information
- Founded
- STRO 2003
- LWAY 1986
- Country
- STRO United States
- LWAY United States
- Employees
- STRO N/A
- LWAY N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- LWAY Packaged Foods
- Sector
- STRO Health Care
- LWAY Consumer Staples
- Exchange
- STRO Nasdaq
- LWAY Nasdaq
- Market Cap
- STRO 172.8M
- LWAY N/A
- IPO Year
- STRO 2018
- LWAY 1987
- Fundamental
- Price
- STRO $1.93
- LWAY $24.76
- Analyst Decision
- STRO Strong Buy
- LWAY Hold
- Analyst Count
- STRO 7
- LWAY 1
- Target Price
- STRO $12.14
- LWAY N/A
- AVG Volume (30 Days)
- STRO 1.3M
- LWAY 61.1K
- Earning Date
- STRO 11-13-2024
- LWAY 11-14-2024
- Dividend Yield
- STRO N/A
- LWAY N/A
- EPS Growth
- STRO N/A
- LWAY 59.90
- EPS
- STRO N/A
- LWAY 0.86
- Revenue
- STRO $160,955,000.00
- LWAY $181,979,000.00
- Revenue This Year
- STRO N/A
- LWAY $19.38
- Revenue Next Year
- STRO N/A
- LWAY $11.79
- P/E Ratio
- STRO N/A
- LWAY $28.80
- Revenue Growth
- STRO 230.90
- LWAY 18.27
- 52 Week Low
- STRO $1.70
- LWAY $9.93
- 52 Week High
- STRO $6.13
- LWAY $28.61
- Technical
- Relative Strength Index (RSI)
- STRO 34.06
- LWAY 56.80
- Support Level
- STRO $1.80
- LWAY $22.55
- Resistance Level
- STRO $2.01
- LWAY $25.01
- Average True Range (ATR)
- STRO 0.16
- LWAY 0.84
- MACD
- STRO 0.02
- LWAY 0.14
- Stochastic Oscillator
- STRO 29.49
- LWAY 90.74
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.